NEW YORK – Metabolon announced on Wednesday that it had closed on $72 million in combined debt and equity financing.
In a statement, company President and CEO Rohan Hastie said that it planned to use the funding to grow its client base and further its R&D programs using machine learning for biomarker discovery and precision medicine.
The round included new investor Perceptive Advisors as well as existing investors including EW Healthcare Partners.